Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BK011
- Development stage
- Phase 1
- Lead developer
- Zhejiang Xinweishengke Biotechnology
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
BK011 (Weituo) is a recombinant anti-EGFR human-mouse chimeric monoclonal antibody developed by Zhejiang Xinwei Shengke Biotechnology. It is designed to target the Epidermal Growth Factor Receptor (EGFR), a transmembrane protein that is frequently overexpressed in various solid tumors and plays a critical role in cell proliferation, survival, and metastasis. By binding to the extracellular domain of EGFR, BK011 inhibits the activation of downstream signaling pathways. The drug is currently being evaluated in Phase 1 clinical trials to assess its safety, tolerability, pharmacokinetics, and preliminary antitumor activity in patients with advanced malignant solid tumors, with a specific focus on esophagogastric cancers that have failed standard therapies.
- Brand names
- Weituo
- Other names
- recombinant anti-EGFR human-mouse chimeric monoclonal antibody
02
Targets
Beyond the preview
Go deeper on BK011.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BK011.